E
Edwards Lifesciences Corporation (EW)
NYQ – Real Time Price. Currency in USD
79.73
+2.56 (3.32%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NYQ – Real Time Price. Currency in USD
79.73
+2.56 (3.32%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.42 | 3.40 | 10 | |
| Quick ratio | 3.63 | 2.52 | 10 | |
| Debt to Equity | 0.07 | 1.11 | 9.0 | |
| Debt to Assets | 0.05 | 1.58 | 9.0 | |
| Interest coverage | N/A | 4.33 | 10 | |
| Weighted average score | 9.6 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 5.38B | 5.01B | 5.44B | 6.07B | 6.30B |
| Gross Profit | 4.22B | 3.97B | 4.29B | 4.73B | 4.92B |
| Operating Income | 1.70B | 1.43B | 1.44B | 1.63B | 1.75B |
| Net Income | 1.52B | 1.40B | 875M | 1.06B | 1.08B |
| EBITDA | 1.87B | 1.57B | 1.60B | 1.79B | 1.91B |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 11.1 | 10.92 | 7.0 |
| Next quarter | 8.86 | 11.49 | 6.5 |
| Current year | 11.39 | 17.58 | 8.0 |
| Next year | 9.91 | 11.99 | 6.5 |
| Weighted average score | 7.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 5.03 | 492.99 | 34.48 | -105.96 | 6.5 |
| Y/Y | 16.7 | 4.24 | 21.88 | -109.39 | 6.0 |
| 3y average | 4.4 | -8.08 | 1.13 | 90.55 | 4.5 |
| 5y average | 7.07 | 11.91 | 6.89 | 71.63 | 6.8 |
| Weighted average score | 6.0 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | Wide | 8.0 |
| Intangible assets | Wide | 8.0 |
| Switching costs | Wide | 9.0 |
| Network effect | Medium | 7.0 |
| Economies of scale | Wide | 8.0 |
| Weighted average score | 8.0 | |
Company's cash reserves $2.4B significantly exceed its total debt $702.9M, ensuring strong financial flexibility
Total current assets $6.2B exceed Total current liabilities $1.4B, highlighting excellent liquidity
Debt-to-equity ratio (0.1) is well below the industry average (1.1), showcasing prudent financial management
The company has no interest-bearing debt, showcasing excellent financial strength
Negative free cash flow -$21.1M limits the company's ability to reinvest or pay down debt